MarketPulse

capital raise

118 articles
The Motley FoolThe Motley Fool··Bram Berkowitz

Tepper Pressures Whirlpool Board Over $963M Capital Raise, Strategic Missteps

David Tepper criticizes Whirlpool's $963M equity raise and strategic missteps. The activist investor questions capital allocation decisions as stock declines 32% amid housing market weakness.
WHRDavid TepperAppaloosa Management
The Motley FoolThe Motley Fool··Rich Smith

Intuitive Machines Shares Slide on $175M Equity Raise Following Lanteris Deal

Intuitive Machines shares fell 16% after announcing a $175M equity raise to fund its $800M Lanteris acquisition, causing significant shareholder dilution.
LUNRacquisitioncapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Immuron Lifts H1 Revenue on U.S. Growth, Pursues Partnership Strategy

Immuron lifted H1 revenue 5% to AUD$4.2M with strong U.S. growth of 17%. The company secured AUD$7.3M funding and is pursuing partnerships to advance its clinical pipeline.
IMRNFDA approvalclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bicara Therapeutics Raises $150M Through Stock and Warrant Offering

Bicara Therapeutics raises $150M through stock and warrant offering to fund lead drug candidate development, expand manufacturing, and build commercial infrastructure.
BCAXEGFRpublic offering
BenzingaBenzinga··Globe Newswire

Bicara Therapeutics Plans $150M Stock Offering to Fund Pipeline Advancement

Bicara Therapeutics plans $150M stock offering to advance its lead drug candidate ficerafusp alfa through clinical development and build commercial infrastructure for potential market launch.
BCAXclinical-stageEGFR
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bimergen Energy Completes $13.6M Equity Offering to Fund Battery Storage Expansion

Bimergen Energy raises $13.6M through equity offering to fund battery storage expansion and strengthen operations amid growing grid-scale energy demand.
BESSpublic offeringcapital raise
BenzingaBenzinga··Globe Newswire

Eupraxia Pharmaceuticals Completes $63.2M Offering to Fund GI Disease Pipeline

Eupraxia Pharmaceuticals raises $63.2M to advance its GI disease pipeline, including EP-104GI trials for eosinophilic esophagitis and other gastrointestinal indications.
EPRXclinical trialspublic offering
BenzingaBenzinga··Globe Newswire

Candel Therapeutics Plans $100M Stock Offering to Fund Cancer Treatment Pipeline

Candel Therapeutics plans $100M stock offering to fund cancer treatment pipeline development, particularly for prostate and lung cancer therapies.
CADLclinical trialpublic offering
BenzingaBenzinga··Lekha Gupta

JIADE Limited Launches $3M Direct Equity Offering

JIADE Limited launches $3M direct equity offering of 12M shares at $0.25 each. Stock fell 8.13% on announcement; potential $12M if all options exercised.
JDZGstock declineequity offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

SKYX Expands Retail Footprint With NVIDIA Partnership and $33M Funding Round

SKYX secures $33M funding and NVIDIA partnership, expanding retail presence across major chains with projections of 100,000+ units by 2026.
NVDASKYXrevenue growthcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Eupraxia Pharmaceuticals Raises $55M Through Public Offering to Fund GI Pipeline

Eupraxia Pharmaceuticals raises $55M via public offering to advance EP-104GI for eosinophilic esophagitis through Phase 2/3 development and expand GI pipeline.
EPRXclinical trialspublic offering
The Motley FoolThe Motley Fool··Jack Delaney

SoFi Technologies Shares Decline 17% Following December Capital Raise

SoFi stock fell 17% in January after a $1.5B capital raise, though the fintech company projects strong 125% net income growth in Q1 2026.
SOFIfintechearnings growth
BenzingaBenzinga··Globe Newswire

Coherus Oncology Raises $50.1M in Stock Offering to Fund Oncology Pipeline

Coherus Oncology raised $50.1M through stock offering to fund commercial launch of LOQTORZI and advance its oncology pipeline development.
CHRSclinical developmentpublic offering
BenzingaBenzinga··Globe Newswire

Liminatus Pharma Prices $4M Share Offering to Fund Immuno-Oncology Pipeline

Liminatus Pharma prices $4M share offering to fund immuno-oncology pipeline development, specifically advancing CD47-blockade therapeutic programs.
LIMNLIMNWwarrantspublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nasus Pharma Closes $15M Capital Raise to Fund Epinephrine Product Development

Nasus Pharma raises $15M to advance intranasal epinephrine product toward FDA trials. Funds support NS002 development and pipeline expansion.
NSRXprivate placementcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Coherus Oncology Raises $50.1M Through Common Stock Offering

Coherus Oncology raises $50.1M via stock offering to fund commercial expansion of LOQTORZI and advance oncology pipeline development programs.
CHRSclinical developmentpublic offering
BenzingaBenzinga··Prnewswire

Hot Chili Secures A$40M Funding Round to Advance Chilean Copper-Gold Operations

Hot Chili raises A$40M to advance its Chilean copper-gold Costa Fuego project, with backing from major investors including Glencore. Funds will support environmental assessments and La Verde integration.
GLNCYinstitutional investorsprivate placement
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Namib Minerals Initiates Redwing Mine Dewatering Program in Zimbabwe

Namib Minerals begins dewatering operations at Zimbabwe's Redwing Mine to assess feasibility for restart. Phase aims to gather geological data for future development decisions.
NAMMNAMMWcapital raiseRedwing Mine